跳至主要内容
临床试验/NCT07604480
NCT07604480已完成不适用

Remimazolam-Propofol Combination Sedation for Gastrointestinal Endoscopy: A Prospective Observational Study

University of Medicine and Pharmacy "Victor Babes" Timisoara1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2024年11月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
29
试验地点
1

研究概览

简要总结

This prospective observational study evaluated the safety and efficacy of a remimazolam-propofol combination sedation protocol in adult patients undergoing elective gastrointestinal endoscopy at a tertiary care centre in Romania. The primary outcome was procedural completion. Secondary outcomes included time to sedation onset, recovery time, discharge readiness, total sedative doses administered, and incidence of adverse events including cardiovascular and respiratory complications.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years Elective upper or lower gastrointestinal endoscopy (gastroscopy or colonoscopy) ASA physical status I-IV Written informed consent obtained prior to enrolment

排除标准

  • Age <18 years ASA physical status V Emergency endoscopic procedures Known allergy or hypersensitivity to remimazolam, propofol, fentanyl, or any component of their formulations Severe hepatic impairment Pregnancy or breastfeeding History of difficult airway or anticipated airway management difficulties Refusal of informed consent Participation in another clinical trial at the time of enrolment

研究者

发起方
University of Medicine and Pharmacy "Victor Babes" Timisoara
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sonia-Elena Popovici

MD, PhD candidate

University of Medicine and Pharmacy "Victor Babes" Timisoara

研究点 (1)

Loading locations...

相似试验